Skip to Main Content

Paper Details

A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma.
Cancers (Basel)
1
2023
Author NameAffiliation
Yu-Ju ChenInstitute of Chemistry
Yu-Ju ChenNational Taiwan University
  • 1 - 2

Datasets

Release 1.2